IMI is planning a fast-track Call for proposals on combatting coronavirus infections (particularly COVID-19) to be launched in early March.
Draft Call documents
Scope of the Call
The scope of the Call is broad and proposals must address one of the following objectives:
- development of antivirals as well as other types of therapeutics to address a rapid response to the current COVID-19 outbreak;
- development of therapeutics to address the current and/or future coronavirus outbreaks;
- development of diagnostics, ensuring rapid evaluation of candidates based on existing technologies;
- development of fast and reliable tools that go beyond the state of the art for detection of COVID-19 carriers and symptomatic individuals suspected of COVID-19 infection.
Preventive vaccines are specifically excluded from the scope of the Call.
IMI will hold a webinar on IMI2 – Call 21 on Wednesday 4 March at 14:30. For details and to register, visit the webinar page.